The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Everolimus in anaplastic thyroid cancer: A case series.
 
Ethan James Harris
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Glenn J. Hanna
No Relationships to Disclose
 
Nicole Grace Chau
Research Funding - GlaxoSmithKline; Merck (Inst); Pfizer (Inst)
 
Guilherme Rabinowits
Stock and Other Ownership Interests - Regeneron; Syros Pharmaceuticals
Consulting or Advisory Role - EMD Serono; Pfizer
Research Funding - EMD Serono (Inst); Exelixis (Inst); Millennium (Inst)
 
Robert I. Haddad
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst); VentiRx (Inst)
 
Danielle Nina Margalit
No Relationships to Disclose
 
Jonathan Daniel Schoenfeld
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Debiopharm Group; Nanobiotix; Tilos Therapeutics
Research Funding - Bristol-Myers Squibb; Merck
 
Roy B. Tishler
No Relationships to Disclose
 
Justine A. Barletta
No Relationships to Disclose
 
Matthew Nehs
No Relationships to Disclose
 
Pasi A. Janne
Stock and Other Ownership Interests - Gatekeeper Pharmaceuticals
Consulting or Advisory Role - Araxes Pharma; ARIAD; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Ignyta; Lilly; LOXO; Merrimack; Mirati Therapeutics; Pfizer; Roche/Genentech
Research Funding - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Lilly; Puma Biotechnology
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a DFCI owned patent on EGFR mutations licensed to Lab Corp. I receive post-marketing royalties from this invention
 
Julian Huang
No Relationships to Disclose
 
Phillip Groden
No Relationships to Disclose
 
Alec Kacew
No Relationships to Disclose
 
Jochen H. Lorch
No Relationships to Disclose